SS Innovations International, Inc. is a medical robotics company, which develops a fully autonomous medical robotic system using proprietary software. The company is headquartered in Fort Lauderdale, Florida and currently employs 483 full-time employees. The company went IPO on 2018-07-09. The Company’s product range includes its proprietary SSi Mantra surgical robotic system and its comprehensive suite of SSi Mudra surgical instruments, which support a variety of surgical procedures including robotic cardiac surgery. The SSi Mantra Surgical Robotic System is designed to enable surgeons to perform a wide range of surgical procedures including cardiovascular, thoracic, head and neck, gynecological, urological, cancer and general surgeries. The SSi Mantra 3 is comprised of components, such as Surgeon Console, Patient-Side Robotic Arm Carts, and Vision Cart. Its instruments under development include NADI-Automated Coronary Anastomotic Connector, SSi Multi-Fire Clip Applier, SSi Ultrasonic Surgical Device, SSi Maya-XR Pre-Operative Simulator, SSi Holographic Anatomy, SSi Yog-Tele Proctor, SSi Chitrasa-Advanced DICOM Viewer and SSi Mixed Reality Headset.
SSII stock price ended at $4.08 on 月曜日, after rising 5.43%
On the latest trading day May 11, 2026, the stock price of SSII rose by 5.43%, climbing from $3.96 to $4.08. During the session, the stock saw a volatility of 6.49%, with prices oscillating between a daily low of $3.85 and a high of $4.10. Notably, trading volume dropped by 11.8K shares on the last day despite the price increase, which may signal a potential uptick in risk in the near term. A total of 36.4K shares were traded, equating to a market value of approximately $816.9M.